ASP Isotopes Inc. Common Stock

NASDAQ ASPI

Data sourced from iex and EODHD
Download Data

ASP Isotopes Inc. Common Stock Enterprise Value to EBITDA (EV/EBITDA) on June 03, 2024: -21.24

ASP Isotopes Inc. Common Stock Enterprise Value to EBITDA (EV/EBITDA) is -21.24 on June 03, 2024, a NA change year over year. The EV/EBITDA ratio compares a company's enterprise value to its EBITDA. It provides insight into the company's valuation relative to its earnings and is commonly used in comparing the relative value of different companies within an industry. A lower ratio suggests a potentially more favorable valuation.
  • ASP Isotopes Inc. Common Stock 52-week high Enterprise Value to EBITDA (EV/EBITDA) is -15.42 on May 14, 2024, which is 27.42% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • ASP Isotopes Inc. Common Stock 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -24.11 on May 24, 2024, which is -13.49% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • ASP Isotopes Inc. Common Stock average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -21.82.
NASDAQ: ASPI

ASP Isotopes Inc. Common Stock

CEO Mr. Paul Elliot Mann
IPO Date Nov. 10, 2022
Location United States
Headquarters 433 Plaza Real, Boca Raton, FL, United States, 33432
Employees 76
Sector Basic Materials
Industry Chemicals
Description

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

StockViz Staff

September 19, 2024

Any question? Send us an email